Serum prosaposin levels are increased in patients with advanced prostate cancer

Prostate

Volumn 72, Issue 3, 2012, Pages 253-269

  Koochekpour, Shahriar ^a,b   Hu, Siyi ^a   Vellasco Gonzalez, Cruz ^a,c   Bernardo, Ruiz ^a   Azabdaftari, Gissu ^b   Zhu, Guodong ^d   Zhau, Haiyen E ^e   Chung, Leland W K ^e   Vessella, Robert L ^f  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d XI'AN JIAOTONG UNIVERSITY   (China)

^e CEDARS SINAI MEDICAL CENTER   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

castrate resistant; metastasis; prosaposin; prostate cancer

Indexed keywords

PROSAPOSIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER TISSUE; CASTRATION RESISTANT PROSTATE CANCER; CONTROLLED STUDY; EMBRYO DEVELOPMENT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ORGANOGENESIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PUBERTY; SEMINAL VESICLE; TISSUE MICROARRAY; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGED; AGING; APOPTOSIS; CASE-CONTROL STUDIES; CASTRATION; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSTATE; PROSTATIC NEOPLASMS; SAPOSINS; SEVERITY OF ILLNESS INDEX; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84855683777     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21427     Document Type: Article

References (38)

1. Wegiel B, Evans S, Hellsten R, Otterbein LE, Bjartell A, Persson JL,. Molecular pathways in the progression of hormone-independent and metastatic prostate cancer. Curr Cancer Drug Targets 2010; 10: 392-401.
2. Isaacs JT,. The biology of hormone refractory prostate cancer. Why does it develop? Urol Clin North Am 1999; 26: 263-273. (Pubitemid 29228223)
3. Lin Y, Wang F,. FGF signalling in prostate development, tissue homoeostasis and tumorigenesis. Biosci Rep 2010; 30: 285-291.
4. Adorini L, Penna G, Fibbi B, Maggi M,. Vitamin D receptor agonists target static, dynamic, and inflammatory components of benign prostatic hyperplasia. Ann N Y Acad Sci 2010; 1193: 146-152.
5. Culig Z, Bartsch G, Hobisch A,. Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth. Mol Cell Endocrinol 2002; 197: 231-238. (Pubitemid 35304797)
6. Culig Z, Hobisch A, Cronauer MV, Raymayr C, Trapman J, Hittmair A, Bartsch G, Klocker H,. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res 1994; 54: 5474-5478.
7. Mackinnon AC, Yan BC, Joseph LJ, Al-Ahmadie HA,. Molecular biology underlying the clinical heterogeneity of prostate cancer: An update. Arch Pathol Lab Med 2009; 133: 1033-1040.
8. Ramirez ML, Keane TE, Evans CP,. Managing prostate cancer: The role of hormone therapy. Can J Urol 2007; 1: 10-18.
9. Fitzpatrick JM,. Is hormone ablation still the right choice for advanced prostate cancer? BJU Int 2007; 100 (Suppl 2): 36-39. (Pubitemid 46985611)
10. Molina A, Belldegrun A,. Novel therapeutic strategies for castration resistant prostate cancer: Inhibition of persistent androgen production androgen receptor mediated signaling. J Urol 2011; 185: 787-794.
11. van Leeuwen PJ, Connolly D, Tammela TL, Auvinen A, Kranse R, Roobol MJ, Schroder FH, Gavin A,. Balancing the harms and benefits of early detection of prostate cancer. Cancer 2010; 116: 4857-4865.
12. Koochekpour S, Zhuang YJ, Beroukhim R, Hsieh CL, Hofer MD, Zhau HE, Hiraiwa M, Pattan DY, Ware JL, Luftig RB, Sandhoff K, Sawyers CL, Pienta KJ, Rubin MA, Vessella RL, Sellers WR, Sartor O,. Amplification and overexpression of prosaposin in prostate cancer. Genes Chromosomes Cancer 2005; 44: 351-364. (Pubitemid 41476786)
13. Schuette CG, Pierstorff B, Huettler S, Sandhoff K,. Sphingolipid activator proteins: Proteins with complex functions in lipid degradation and skin biogenesis. Glycobiology 2001; 11: 81R-90R. (Pubitemid 32655236)
14. Kishimoto Y, Hiraiwa M, O'Brien JS,. Saposins. Structure, function, distribution and molecular genetics. J Lipid Res 1992; 33: 1255-1267.
15. Koochekpour S,. PSAP (Prosaposin (variant Gaucher disease and variant metachromatic leukodystrophy)) Atlas Genet Cytogenet Oncol Haematol 2006.
16. Morales CR, Zhao Q, El-Alfy M, Suzuki K,. Targeted disruption of the mouse prosaposin gene affects the development of the prostate gland and other male reproductive organs. J Androl 2000; 21: 765-775.
17. Elleder M, Jerabkova M, Befekadu A, Hřebíček M, Berná L, Ledvinová J, Hůlková H, Rosewich H, Schymik N, Paton BC, Harzer K,. Prosaposin deficiency, a rale diagnosed, rapidly progressing, neonatal neurovisceral lipid storage disease. Report of a further patient. Neuropediatrics 2005; 36: 171-180. (Pubitemid 41117113)
18. Hulková M, Cervenková M, Ledvinová J, Tochácková M, Hrebícek M, Poupetová H, Befekadu A, Berná L, Paton BC, Harzer K, Böör A, Smíd F, Elleder M,. A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated lactosylceramide accumulation. Hum Mol Genet 2001; 9: 927-940. (Pubitemid 32401409)
19. Tylki-Szymańska A, Czartoryska B, Vanier MT, Poorthuis BJ, Groener JA, Augowska A, Millat G, Vaccaro AM, Jurkiewicz E,. Non-neuronopathic Gaucher disease due to saposin C deficiency. Clin Genet 2007; 72: 538-542. (Pubitemid 350131059)
20. Lee TJ, Sartor O, Luftig RB, Koochekpour S,. Saposin C promotes survival and prevents apoptosis via PI3K/Akt-dependent pathway in prostate cancer cells. Mol Cancer 2004; 17 (3): 31.
21. Koochekpour S, Sartor O, Hiraiwa M, Lee TJ, Rayford W, Remmel N, Sandhoff K, Minokadeh A, Patten DY,. Saposin C stimulates growth and invasion, activates p42/44 and SAPK/JNK signaling pathways of MAPK and upregulates uPA/uPAR expression in prostate cancer and stromal cells. Asian J Androl 2005; 7: 147-158. (Pubitemid 41051420)
22. Koochekpour S, Sartor O, Lee TJ, Zieske A, Patten DY, Hiraiwa M, Sandhoff K, Remmel N, Minokadeh A,. Prosaptide TX14A stimulates growth, migration, and invasion and activates the Raf-MEK-ERK-RSK-Elk-1 signaling pathway in prostate cancer cells. Prostate 2004; 61: 114-123. (Pubitemid 39244698)
23. Hu S, Delorme N, Liu Z, Liu T, Velasco-Gonzalez C, Garai J, Pullikuth A, Koochekpour S,. Prosaposin down-modulation decreases metastatic prostate cancer cell adhesion, migration, and invasion. Mol Cancer 2010; 9: 30.
24. Qi X, Leonova T, Grabowski GA,. Functional human saposins expressed in Escherichia coli. Evidence for binding and activation properties of saposins C with acid beta-glucosidase. J Biol Chem 1994; 269: 16746-16753.
25. van Agthoven T, Bosma PT, Nooter K, Dorssers LC,. Functional screen for genes responsible for tamoxifen resistance in human breast cancer cells. Mol Cancer Res 2006; 4: 379-386. (Pubitemid 44035157)
26. Meijer D, Jansen MP, Look MP, Ruigrok-Ritstier K, van Staveren IL, Sieuwerts AM, van Agthoven T, Foekens JA, Dorssers LC, Berns EM,. TSC22D1 and PSAP predict clinical outcome of tamoxifen treatment in patients with recurrent breast cancer. Breast Cancer Res Treat 2009; 113: 253-260.
27. Koochekpour S, Lee TJ, Wang R, Culig Z, Delorme N, Caffey S, Marrero L, Aguirre J,. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP). Prostate 2007; 67: 178-189. (Pubitemid 46185321)
28. Koochekpour S, Lee TJ, Sun Y, Hu S, Grabowski GA, Liu Z, Garay J,. Prosaposin is an AR-target gene and its neurotrophic domain upregulates AR expression and activity in prostate stromal cells. J Cell Biochem 2008; 104: 2272-2285.
29. Koochekpour S, Lee TJ, Wang R, Sun Y, Delorme N, Hiraiwa M, Grabowski GA, Culig Z, Minokadeh A,. Prosaposin is a novel androgen-regulated gene in prostate cancer cell line LNCaP. J Cell Biochem 2007; 10: 631-641. (Pubitemid 46698848)
30. Campana WM, O'Brien JS, Hiraiwa M, Patton S,. Secretion of prosaposin, a multifunctional protein, by breast cancer cells. Biochim Biophys Acta 1999; 1427: 392-400. (Pubitemid 29229761)
31. Ding Y, Wang X, Xu A, Xu X, Tian K, Young CY, Yuan H,. Associations of saposin C, Src, and androgen receptor upregulate the expression and function of androgen receptor in human prostate cancer cells. J Cell Biochem 2011; 112: 818-828.
32. Ding Y, Yuan HQ, Kong F, Hu XY, Ren K, Cai J, Wang XL, Young CY,. Ectopic expression of neurotrophic peptide derived from saposin C increases proliferation and upregulates androgen receptor expression and transcriptional activity in human prostate cancer cells. Asian J Androl 2007; 9: 601-609. (Pubitemid 47354662)
33. Patton S, Carson GS, Hiraiwa M, O'Brien JS, Sano A,. Prosaposin, a neurotrophic factor: Presence and properties in milk. J Dairy Sci 1997; 80: 264-272. (Pubitemid 127447018)
34. Kondoh K, Hineno T, Sano A, Kakimoto Y,. Isolation and characterization of prosaposin from human milk. Biochem Biophys Res Commun 1991; 181: 286-292.
35. Guyton AC, Hall JE,. The pituitary hormones and their control by the hypothalamus. In:, Guyton AC, Hall JE, editors. Textbook of medical physiology. New York: Saunders; 2000. pp. 846-857.
36. Sun L, Wang S, Hu C, Zhang X,. Regulation of cell proliferation and apoptosis through fibrocystin-prosaposin interaction. Arch Biochem Biophys 2010; 502: 130-136.
37. Li N, Sarojini H, An J, Wang E,. Prosaposin in the secretome of marrow stroma-derived neural progenitor cells protects neural cells from apoptotic death. J Neurochem 2010; 112: 1527-1538.
38. Clarkson RW, Boland MP, Kritikou EA, Lee JM, Freeman TC, Tiffen PG, Watson CJ,. The genes induced by signal transducer and activators of transcription (STAT)3 and STAT5 in mammary epithelial cells define the roles of these STATs in mammary development. Mol Endocrinol 2006; 20: 675-685. (Pubitemid 43291217)